# Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?

> **NCT00215631** · PHASE3 · TERMINATED · sponsor: **Erasmus Medical Center** · enrollment: 100 (—)

## Conditions studied

- Prostate Cancer
- Erectile Dysfunction

## Interventions

- **DRUG:** tadalafil

## Key facts

- **NCT ID:** NCT00215631
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 100 (—)
- **Why stopped:** slow recruitment
- **Last updated:** 2015-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00215631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00215631, "Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00215631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
